• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Elucidation for molecular mechanisms of neoplastic cell transformation

Research Project

Project/Area Number 23300347
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Tumor biology
Research InstitutionJikei University School of Medicine (2012-2013)
Tokyo Medical and Dental University (2011)

Principal Investigator

YOSHIDA Kiyotsugu  東京慈恵会医科大学, 医学部, 教授 (70345312)

Project Period (FY) 2011-04-01 – 2014-03-31
Project Status Completed (Fiscal Year 2013)
Budget Amount *help
¥21,450,000 (Direct Cost: ¥16,500,000、Indirect Cost: ¥4,950,000)
Fiscal Year 2013: ¥8,580,000 (Direct Cost: ¥6,600,000、Indirect Cost: ¥1,980,000)
Fiscal Year 2012: ¥6,370,000 (Direct Cost: ¥4,900,000、Indirect Cost: ¥1,470,000)
Fiscal Year 2011: ¥6,500,000 (Direct Cost: ¥5,000,000、Indirect Cost: ¥1,500,000)
KeywordsDNA傷害 / アポトーシス / ユビキチン化 / プロテオミクス / 癌 / リン酸化酵素 / 細胞周期
Research Abstract

Dysregulation of the G1/S transition in the cell cycle contributes to tumor development. Degradation of c-Jun/c-Myc is a critical process for the G1/S transition. We found DYRK2 functioning as a priming kinase, whose phosphorylation of c-Jun/c-Myc precedes and is required for subsequent GSK3beta phosphorylation. DYRK2 silencing shortened the G1 phase to accelerate cell proliferation due to their escape from ubiquitination-mediated degradation.
EMT plays a fundamental role in the early stages of breast cancer invasion. Snail is an important regulator of EMT. We identified that DYRK2 regulates Snail stability. Knockdown of DYRK2 promoted EMT and cancer invasion in vitro and in vivo.
p53 phosphorylation at Ser46 exerts apoptotic cell death. We found that amphiregulin (AREG) is identified for a direct target of Ser46 phosphorylation. AREG interacted with DDX5. AREG regulated precursor microRNA processing with DDX5 to reduce the expression of anti-apoptotic protein Bcl-2.

Report

(4 results)
  • 2013 Annual Research Report   Final Research Report ( PDF )
  • 2012 Annual Research Report
  • 2011 Annual Research Report
  • Research Products

    (19 results)

All 2014 2013 2012 2011 Other

All Journal Article (7 results) (of which Peer Reviewed: 7 results,  Open Access: 1 results) Presentation (8 results) (of which Invited: 1 results) Book (2 results) Remarks (2 results)

  • [Journal Article] Induction of amphiregulin by p53 promotes apoptosis via control of microRNA biogenesis in response to DNA damage2014

    • Author(s)
      Taira N, Yamaguchi T, Kimura J, Lu Z-G, Fukuda S, Higashiyama S, Ono M, Yoshida K
    • Journal Title

      Proc. Natl. Acad. Sci. USA

      Volume: 111 Issue: 2 Pages: 717-722

    • DOI

      10.1073/pnas.1313675111

    • Related Report
      2013 Annual Research Report 2013 Final Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] DYRK2 controls epithelial-mesenchymal transition in breast cancer by degrading Snail2013

    • Author(s)
      Mimoto R, Taira N, Takahashi H, Yamaguchi T, Okabe M, Uchida K, Miki Y, Yoshida K
    • Journal Title

      Cancer Lett

      Volume: 339 Issue: 2 Pages: 214-225

    • DOI

      10.1016/j.canlet.2013.06.005

    • Related Report
      2013 Annual Research Report 2013 Final Research Report
    • Peer Reviewed
  • [Journal Article] DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells2012

    • Author(s)
      Taira N., et al
    • Journal Title

      The Journal of Clinical Investigation

      Volume: 122 Issue: 3 Pages: 859-872

    • DOI

      10.1172/jci60818

    • Related Report
      2013 Final Research Report 2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Programmed cell death 6, a novel p53-responsive gene, targets to the nucleus in the apoptotic response to DNA damage.2012

    • Author(s)
      Kazuho Suzuki
    • Journal Title

      Cancer Sci.

      Volume: 103 Issue: 10 Pages: 1788-1794

    • DOI

      10.1111/j.1349-7006.2012.02362.x

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Journal Article] DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells2012

    • Author(s)
      Taira, et al
    • Journal Title

      J Clin.Invest.

      Volume: 122 Pages: 859-872

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] PKCdelta regulates Mdm2 independently of p53 in the apoptotic response to DNA damage2011

    • Author(s)
      Hew, et al
    • Journal Title

      Mol.Carcinog.

      Volume: 50 Pages: 719-731

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Identification of Evi-1 as a novel effector of PKCdelta in the apoptotic response to DNA damage2011

    • Author(s)
      Hew, et al
    • Journal Title

      Biochim.Biopbys.Acta

      Volume: 1803 Pages: 285-294

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Presentation] 細胞死及びmicroRNA代謝制御に関わる新規p53関連遺伝子の同定2013

    • Author(s)
      平直江 他
    • Organizer
      第72回日本癌学会学術総会
    • Place of Presentation
      横浜
    • Related Report
      2013 Annual Research Report
  • [Presentation] Mps1/TKは分裂期染色体凝集を制御する2013

    • Author(s)
      加賀美裕也 他
    • Organizer
      第72回日本癌学会学術総会
    • Place of Presentation
      横浜
    • Related Report
      2013 Annual Research Report
  • [Presentation] P53 targets isoform of paralemmin protein in a serine 46 specific manner to promote apoptosis2013

    • Author(s)
      Nurmaa DASHZEVEG, et al.
    • Organizer
      第72回日本癌学会学術総会
    • Place of Presentation
      横浜
    • Related Report
      2013 Annual Research Report
  • [Presentation] Epoxomicin耐性細胞はDUSP6/MKP3発現消失に伴いZEB1発現を誘導しE-cadherin発現消失を促す2013

    • Author(s)
      朝倉正 他
    • Organizer
      第72回日本癌学会学術総会
    • Place of Presentation
      横浜
    • Related Report
      2013 Annual Research Report
  • [Presentation] DYRK2 phosphorylation of c-Jun/c-Myc controls tumor progression by monitoring G1/S transition.2013

    • Author(s)
      Kiyotsugu Yoshida
    • Organizer
      1st International Symposium on Protein Modifications in Pathogenic Dysregulation of Signaling
    • Place of Presentation
      Tokyo, Japan
    • Related Report
      2012 Annual Research Report
    • Invited
  • [Presentation] 細胞死誘導と細胞周期制御による発癌抑制の分子機構2012

    • Author(s)
      吉田清嗣
    • Organizer
      第3次対がん10か年総合戦略・文科省がん支援活動 合同公開シンポジウム
    • Place of Presentation
      東京
    • Year and Date
      2012-01-31
    • Related Report
      2013 Final Research Report
  • [Presentation] 細胞死誘導と細胞周期制御による発癌抑制の分子機構2012

    • Author(s)
      吉田清嗣
    • Organizer
      第3次対がん10か年総合戦略・文科省がん支援活動合同公開シンポジウム
    • Place of Presentation
      東京
    • Year and Date
      2012-01-31
    • Related Report
      2011 Annual Research Report
  • [Presentation] Role for DYRK2 in cell cycle control and tumor progression.2012

    • Author(s)
      Kiyotsugu Yoshida
    • Organizer
      MMC2012
    • Place of Presentation
      Bangkok, Thailand
    • Related Report
      2012 Annual Research Report
  • [Book] Functional role for the c-Abl tyrosine kinase signalling in the DNA damage response. In : Kimura S and Shimizu S (eds), DNA repair : New Research2012

    • Author(s)
      Yoshida K
    • Publisher
      Nova Science Publishers, Inc
    • Related Report
      2013 Final Research Report
  • [Book] Role for PKCδ on apoptosis in the DNA damage response. In : Clark C. Chen (ed), Selected T opics in DNA Repair2011

    • Author(s)
      Yoshida K
    • Publisher
      InTech
    • Related Report
      2013 Final Research Report
  • [Remarks]

    • URL

      http://jikei-biochem.wix.com/yoshidalab

    • Related Report
      2013 Final Research Report
  • [Remarks] 東京慈恵会医科大学生化学講座ホームページ

    • URL

      http://jikei-biochem.wix.com/yoshidalab

    • Related Report
      2013 Annual Research Report

URL: 

Published: 2011-04-06   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi